ASX-LISTED digital medication management company MedAdvisor has announced the appointment of two key personnel as part of its expansion drive into the US market.
The additions include James Rotsart, Executive Vice President of Adheris Inc which is the largest US provider of tailored direct-to-patient medication adherence programs.
Also joining the team is Adheris co-founder Lucas Merrow, who also established Eliza Corporation which provided healthcare programs to major US health insurers and Pharmaceutical Benefits Managers.
MedAdvisor CEO Robert Read said "we are pleased to have attracted such high calibre industry players to help drive expansion into the US market...expansion beyond the Australian market is a key part of our growth strategy and our track record in Australia is highly regarded by companies internationally."
Read noted that the US market has some 65,000 pharmacies, with non-adherence estimated to cost as much as US$100 billion annually.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Oct 18
